Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: Data from the Euro Heart Survey

European Heart Journal

Volumn 29, Issue 5, 2008, Pages 632-639

  De Vos, Cees B ^a   Nieuwlaat, Robby ^a   Crijns, Harry J G M ^a   Camm, A John ^b   Leheuzey, Jean Yves ^c   Kirchhof, Charles J ^d   Capucci, Alessandro ^e   Breithardt, Günter ^f   Vardas, Panos E ^g   Pisters, Ron ^a   Tieleman, Robert G ^a,h  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d RIJNLAND HOSPITAL   (Netherlands)

^e GUGLIELMO DA SALICETO HOSPITAL   (Italy)

^f UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^g UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^h MARTINI HOSPITAL   (Netherlands)

Author keywords

Adrenergic; Antiarrhythmia agents; Atrial fibrillation; Autonomic nervous system; Guideline adherence; Vagal

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROPAFENONE; SOTALOL;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CLINICAL FEATURE; DISEASE EXACERBATION; EMOTION; EXERCISE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; VAGUS NERVE; AUTONOMIC NEUROPATHY; HEALTH SURVEY; MIDDLE AGED; PAROXYSMAL TACHYCARDIA; PRACTICE GUIDELINE; STANDARD;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; AUTONOMIC NERVOUS SYSTEM DISEASES; FEMALE; GUIDELINE ADHERENCE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; TACHYCARDIA, PAROXYSMAL;

EID: 48049116711     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn025     Document Type: Article

References (18)

1. Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 2001;37:371-378.
2. Coumel P. Cardiac arrhythmias and the autonomic nervous system. J Cardiovasc Electrophysiol 1993;4:338-355.
3. Coumel P. Paroxysmal atrial fibrillation: a disorder of autonomic tone? Eur Heart J 1994;15(Suppl. A):9-16. (Pubitemid 24158556)
4. Coumel P. Autonomic influences in atrial tachyarrhythmias. J Cardiovasc Electrophysiol 1996;7:999-1007.
5. Coumel P, Thomas O, Leenhardt A. Drug therapy for prevention of atrial fibrillation. Am J Cardiol 1996;77:3A-9A.
6. Coumel P. Clinical approach to paroxysmal atrial fibrillation. Clin Cardiol 1990;13:209-212.
7. Chen J, Wasmund SL, Hamdan MH. Back to the future: the role of the autonomic nervous system in atrial fibrillation. Pacing Clin Elec-trophysiol 2006;29:413-421.
8. Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation 2002;105: 2753-2759.
9. Tomita T, Takei M, Saikawa Y, Hanaoka T, Uchikawa S, Tsutsui H, Aruga M, Miyashita T, Yazaki Y, Imamura H, Kinoshita O, Owa M, Kubo K. Role of autonomic tone in the initiation and termination of paroxysmal atrial fibrillation in patients without structural heart disease. J Cardiovasc Electrophysiol 2003;14:559-564.
10. Zimmermann M, Kalusche D. Fluctuation in autonomic tone is a major determinant of sustained atrial arrhythmias in patients with focal ectopy originating from the pulmonary veins. J Cardiovasc Electrophysiol 2001;12:285-291.
11. Fioranelli M, Piccoli M, Mileto GM, Sgreccia F, Azzolini P, Risa MP, Francardelli RL, Venturini E, Puglisi A. Analysis of heart rate variability five minutes before the onset of paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 1999;22:743-749.
12. Bertaglia E, Zoppo F, Bonanno C, Pellizzari N, Frigato N, Pascotto P. Autonomic modulation of the sinus node following electrical cardioversion of persistent atrial fibrillation: relation with early recurrence. Int J Cardiol 2005;102:219-223.
13. Kanoupakis EM, Manios EG, Mavrakis HE, Kaleboubas MD, Parthenakis FI, Vardas PE. Relation of autonomic modulation to recurrence of atrial fibrillation following cardioversion. Am J Cardiol 2000;86:954-958.
14. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257-e354.
15. Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, Davies DW, Cobbe S, Breithardt G, Le Heuzey JY, Prins MH, Levy S, Crijns HJ. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2005;26:2422-2434.
16. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002;54: 230-246.
17. Olshansky B. Interrelationships between the autonomic nervous system and atrial fibrillation. Prog Cardiovasc Dis 2005;48:57-78.
18. van den Berg MP, Crijns HJ, Haaksma J, Brouwer J, Lie KI. Analysis of vagal effects on ventricular rhythm in patients with atrial fibrillation. Clin Sci (Lond) 1994;86:531-535.